Search the Health Library
Get the facts on diseases, conditions, tests and procedures.
I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
Share this page: More
Catheter Ablation versus Antiarrhythmic Drug Therapy for Atril Fibrillation (CABANA)
|Summary of Trial: |
The purpose of this multicenter, comparative, randomized (1:1) study is to compare the effect of percutaneous catheter ablation versus current medical therapy on total mortality among patients with atrial fibrillation.
|Principal Investigator:||Dr. Hugh Calkins|
Kathy Avara, Research Coordinator
|Study Long Title:|
Catheter Ablation versus Antiarrhythmic Drug Therapy for Atril Fibrillation
|Study Short Title:||CABANA|
|JHU IRB Number:|
|Funding Source:||Biosense Webster, Inc., National Heart, Lung and Blood Institute, & St. Jude Medical|
Inclusions / Exclusions:
Patients who have new onset or under-treated paroxysmal, persistent, or longstanding persistent atrial fibrillation and who warrant therapy for their arrhythmia will be considered for enrollment.
If a subject has any of the following criteria, he or she may not be enrolled in the study:
|Clinical Trial Site:|
Johns Hopkins Hospital
|Anticipated End Date:||2009|
|Compensation for Participating:||None|